Dun & Bradstreet Investors Face November 10 Lead Plaintiff Deadline in Securities Fraud Lawsuit
Rosen Law Firm has filed a securities fraud lawsuit against Dun & Bradstreet Holdings, Inc. Investors who sold shares during a specific period or participated in the company's merger may be eligible to act as lead plaintiff by November 10, 2026.
A securities fraud lawsuit has been filed against Dun & Bradstreet Holdings, Inc. (NYSE: DNB), with the deadline for investors to potentially serve as lead plaintiff approaching on November 10, 2026. The action was initiated by Rosen Law Firm, which specializes in investor rights.
The lawsuit targets individuals or entities that sold shares of D&B common stock on the open market between May 13, 2025, and August 26, 2025. It also includes those who exchanged their shares in the company's merger with affiliates of Clearlake Capital Group for $9.15 per share on August 26, 2025, and shareholders of record as of May 9, 2025, whose shares were voted on the merger.
According to the complaint, Dun & Bradstreet's March 23, 2025, merger announcement and May 13, 2025, proxy statement allegedly contained materially false and misleading statements. The suit claims investors were misled regarding the company's true value and the nature of the transaction. Specifically, allegations include the omission of executive chairman Foley's personal interest in a quick sale, undisclosed valuations of superior alternatives to a whole-company sale, and the failure to disclose material ties between Foley and the company's financial and legal advisors.
Rosen Law Firm, which represents investors globally in securities class actions, encourages those who believe they have suffered damages to contact them for information regarding the class action. The firm highlights its track record in recovering substantial sums for investors in similar litigation.